AIDS therapy

AIDS therapy

HIV treatment may be: preventive-eg to prevent in utero infection of HIV-positive mothers; prophylactic-eg to prevent opportunistic infections when CD4 levels fall below certain level; based on efficacy. See AIDS fraud, AIDS quackery, AIDS vaccine.
References in periodicals archive ?
Big laws like ObamaCare are designed by special-interest groups, such as the 'insurance' (managed care) cartel, Big Hospitals, Big Pharma, and influential groups that want their benefits (abortion, contraception, drug and alcohol rehab, AIDS therapy, etc.
These genes may provide novel targets for AIDS therapy.
In this third edition of AIDS Therapy, the authors have combined the efforts of international experts to fulfill this goal.
This drug, a triple combination AIDS therapy, was the first product to be approved by Health Canada under the provisions of the CAMR.
Stuart Rennie and Frieda Behets's article, "AIDS Care and Treatment in Sub-Saharan Africa: Implementation Ethics," is a landmark work that highlights the particular ethical challenges of rationing AIDS therapy in this part of the world.
Indian-made products that combine two or three medicines in one pill has brought the cost of first-line AIDS therapy in Africa down to around $140-$400 per patient a year, he estimates.
Chapter 9 covers Hericium erinaceus and its prospect for cures of Alzheimer's disease, sarcoma, and positive effects on the immune system, and Chapter 10 describes Shiitake--Lentinus edodes in AIDS therapy and as a tool to prevent tooth decay.
On July 20 an erroneous Reuters report on structured treatment interruption (STI -- also called structured intermittent therapy, or SIT), titled "Experts Caution Against an AIDS Therapy," appeared in several newspapers, including the Web site of The New York Times.
Bristol-Myers, based in New York, sells Zerit and Videx, which are also important parts of AIDS therapy.
Bulk anti-infectives will gain strong momentum from the increasing use of protease inhibitors in AIDS therapy.
Improved opportunities exist for antibiotics and anti-infectives due to expanding use in adjunct cancer and AIDS therapy, as well as the introduction of third-generation cephalosporins, macrolides and quinolones.
Some palliative progress, but not a cure, has been achieved since then-notably the drug AZT, which got fast-track approval several years ago and is now the mainstay of AIDS therapy for those who have the money to pay for it.

Full browser ?